Here are relevant reports on : agile-software-development-market
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Multiexperience Development Platforms Market by Component (Platforms, Services), Deployment Type (On-premises, Cloud), Organization Size (Large Enterprises, SMEs), Vertical (BFSI, IT & Telecom) and Region - Global Forecast to 2027
The global multiexperience development platforms market is projected to reach USD 7.2 billion by 2027 at a CAGR of 21.8% during the forecast period. Some prominent players across all service types profiled in the multiexperience development platforms market study include Salesforce (US), SAP (Germany), Outsystems (US), Oracle (US), Microsoft (US), Mendix (US), Pegasystems (US), Progress (US), IBM (US), and ServiceNow (US).
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Digital Education Market by Learning Model (Self-paced, Blended, Microlearning, Adaptive, Mobile), Course Type (Academic, Test Preparation, Professional Certification & Skill Development, Vocational Training, Corporate Training) - Global Forecast to 2030
The digital education market is projected to grow from USD 32.36 billion in 2025 to USD 95.70 billion by 2030 at a compound annual growth rate (CAGR) of 24.2% during the forecast period. Some of the digital education vendors are Udemy (US), Coursera (US), LinkedIn Learning (US), Pluralsight (US), edX (US), Udacity (US), Intellipaat (India), Swayam (India), Veranda Learning (India), and Alison (Ireland).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
US Cloud Computing Market by Service Model (IaaS [Compute, Storage, Networking], PaaS [Application Development & Integration, Database & Data Analytics & Reporting], SaaS [CRM, SCM, Collaboration & Productivity]), Impact of AI - Forecast to 2030
The US cloud computing market is expanding rapidly, with its size anticipated to reach USD 721.30 billion by 2030 from an estimated USD 485.54 billion in 2025, featuring a CAGR of 8.2%. Some of the major players in the US cloud computing market include Google (US), Salesforce (US), Microsoft (US), AWS (US), and Oracle (US).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cloud Computing Market by Service Model (IaaS [Compute, Storage, Networking], PaaS [Application Development & Integration, Database & Data Analytics & Reporting], SaaS [CRM, SCM, Collaboration & Productivity]), Impact of AI - Forecast to 2030
The cloud computing market in Asia Pacific is expected to grow from USD 348.75 billion in 2025 to USD 752.78 billion by 2030, at a CAGR of 16.6%. The major players in the Asia Pacific cloud computing market include Microsoft (US), Google (US), AWS (US), IBM (US), Oracle (US), Tencent Cloud (China), Alibaba Cloud (China), Huawei (China), NTT Data Corporation (Japan), Fujitsu (Japan), NEC Corporation (Japan), Reliance Jio (India), OneAsia (Hong Kong), and CtrlS (India).
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
